In a finding that suggests Ozempic and Wegovy have powers that extend beyond weight loss, a new study finds the medications ...

Patients taking Ozempic were about 60% less likely to have an opioid overdose compared to those taking other diabetes drugs.

The health benefits of blockbuster weight loss drugs are bridging the stark political divide in the United States.

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

WASHINGTON—U.S. Senator Mike Braun questioned Novo Nordisk CEO, Lars Fruergaard Jørgensen, at the Senate Health, Education, ...

The results of Novo Nordisk’s phase 1 trials shows the oral weight loss pill could be more effective than semaglutide.

Cantor Fitzgerald Managing Director Louise Chen noted that price of weight loss drugs from Novo Nordisk and Eli Lilly should ...

Viking Therapeutics, Inc.'s stock surged 1,500% on the promising obesity drug VK-2735, with Phase 3 trials and potential for ...

BioAge Labs, a biopharmaceutical startup focused on obesity drugs, is looking to raise nearly $200 million in its recently ...

The results suggest Ozempic could potentially become a new alternative treatment for opioid use disorder, which could help ...

People with a history of opioid abuse who took Novo Nordisk A/S’s Ozempic were less likely to overdose, according to a study ...

On Capitol Hill lawmakers grilled the CEO of the company that makes popular weight loss drugs Ozempic and Wegovy.